Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Recruiting · NCT06931080 · Registry updated 2025-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients | attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder | Recruiting | Phase 2 / Phase 3 | 2025-08-03 | NCT06931080 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Otsuka Pharmaceutical Co., Ltd. | 22 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Maynds Tower Mental Clinic | Tokyo | Japan | 4 |